Literature DB >> 5068673

An educational program in digitalis therapy.

R I Ogilvie, J Ruedy.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5068673

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  21 in total

1.  Pharmacokinetics in the aged: a review.

Authors:  E J Triggs; R L Nation
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Adverse events: past and future.

Authors:  John Ruedy; Richard I Ogilvie
Journal:  CMAJ       Date:  2004-09-14       Impact factor: 8.262

3.  Pharmacokinetics in the elderly.

Authors:  E J Triggs; R L Nation; A Long; J J Ashley
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

4.  Prescribing to the elderly: a review of the english language canadian literature.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1989-08       Impact factor: 3.275

5.  Drug treatment of cardiac failure.

Authors:  M R Achong; C R Kumana
Journal:  Can Fam Physician       Date:  1982-01       Impact factor: 3.275

6.  Serum digoxin test in perspective.

Authors:  A Dodek
Journal:  Can Med Assoc J       Date:  1977-11-05       Impact factor: 8.262

Review 7.  Digoxin therapy: textbooks, theory and practice.

Authors:  J K Aronson; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

8.  The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing.

Authors:  G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

9.  Therapeutic drug monitoring of digoxin: help or hindrance?

Authors:  R J Dobbs; P W Nicholson; M J Denham; S M Dobbs; C J O'Neill
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of digoxin in infants.

Authors:  G Wettrell; K E Andersson
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.